113 related articles for article (PubMed ID: 32474759)
1. Impact of Serum γ-Glutamyltransferase on Overall Survival in Patients with Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy.
Takemura K; Yuasa T; Inamura K; Amori G; Koga F; Board PG; Yonese J
Target Oncol; 2020 Jun; 15(3):347-356. PubMed ID: 32474759
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of serum γ-glutamyltransferase in patients with advanced urothelial carcinoma.
Takemura K; Fukushima H; Ito M; Kataoka M; Nakanishi Y; Sakamoto K; Suzuki H; Tobisu KI; Koga F
Urol Oncol; 2019 Feb; 37(2):108-115. PubMed ID: 30478012
[TBL] [Abstract][Full Text] [Related]
3. Pretherapeutic gamma-glutamyltransferase is an independent prognostic factor for patients with renal cell carcinoma.
Hofbauer SL; Stangl KI; de Martino M; Lucca I; Haitel A; Shariat SF; Klatte T
Br J Cancer; 2014 Oct; 111(8):1526-31. PubMed ID: 25117808
[TBL] [Abstract][Full Text] [Related]
4. Preoperative serum-gamma-glutamyltransferase (GGT) does not represent an independent prognostic factor in a European cohort of patients with non-metastatic renal cell carcinoma.
Dalpiaz O; Pichler M; Mrsic E; Reitz D; Krieger D; Venturino L; Bezan A; Stojakovic T; Pummer K; Zigeuner R; Hutterer GC
J Clin Pathol; 2015 Jul; 68(7):547-51. PubMed ID: 25862811
[TBL] [Abstract][Full Text] [Related]
5. Serum Exosomal Gamma-Glutamyltransferase Activity Increased in Patients with Renal Cell Carcinoma with Advanced Clinicopathological Features.
Horie K; Kawakami K; Fujita Y; Matsuda Y; Arai T; Suzui N; Miyazaki T; Koie T; Mizutani K; Ito M
Oncology; 2020; 98(10):734-742. PubMed ID: 32726790
[TBL] [Abstract][Full Text] [Related]
6. Association of gamma-glutamyltransferase with severity of disease at diagnosis and prognosis of ovarian cancer.
Grimm C; Hofstetter G; Aust S; Mutz-Dehbalaie I; Bruch M; Heinze G; Rahhal-Schupp J; Reinthaller A; Concin N; Polterauer S
Br J Cancer; 2013 Aug; 109(3):610-4. PubMed ID: 23921280
[TBL] [Abstract][Full Text] [Related]
7. Predictive role of γ-glutamyltransferase in patients receiving nivolumab therapy for metastatic renal cell carcinoma.
Ishiyama Y; Kondo T; Tachibana H; Ishihara H; Fukuda H; Yoshida K; Takagi T; Iizuka J; Tanabe K
Int J Clin Oncol; 2021 Mar; 26(3):552-561. PubMed ID: 33135126
[TBL] [Abstract][Full Text] [Related]
8. Impact of Serum γ-Glutamyltransferase on Overall Survival in Men with Metastatic Castration-Resistant Prostate Cancer Treated with Docetaxel.
Une M; Takemura K; Inamura K; Fukushima H; Ito M; Kobayashi S; Yuasa T; Yonese J; Board PG; Koga F
Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771748
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of pretherapeutic gamma-glutamyltransferase on patients with nasopharyngeal carcinoma.
Wen YF; Yang XZ; Zeng LS; Peng HH; Huang WJ; Cai LM; Zhou TC; Lin XD
PLoS One; 2017; 12(2):e0172345. PubMed ID: 28241022
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of pretreatment serum alanine aminotransferase/aspartate aminotransferase (ALT/AST) ratio and gamma glutamyltransferase (GGT) in patients with esophageal squamous cell carcinoma.
Huang H; Wang XP; Li XH; Chen H; Zheng X; Lin JH; Kang T; Zhang L; Chen PS
BMC Cancer; 2017 Aug; 17(1):544. PubMed ID: 28806937
[TBL] [Abstract][Full Text] [Related]
11. Preoperative Gamma-Glutamyltransferase Is Associated with Cancer-Specific Survival and Recurrence-Free Survival of Nonmetastatic Renal Cell Carcinoma with Venous Tumor Thrombus.
Luo C; Xu B; Fan Y; Yu W; Zhang Q; Jin J
Biomed Res Int; 2017; 2017():3142926. PubMed ID: 28168196
[No Abstract] [Full Text] [Related]
12. Prognostic impact of the pretreatment aspartate transaminase/alanine transaminase ratio in patients treated with first-line systemic tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma.
Kang M; Yu J; Sung HH; Jeon HG; Jeong BC; Park SH; Jeon SS; Lee HM; Choi HY; Seo SI
Int J Urol; 2018 Jun; 25(6):596-603. PubMed ID: 29756394
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of preoperative serum gamma-glutamyltranspeptidase in patients with hepatocellular carcinoma after hepatectomy.
Fu S; Guo Z; Li S; Kuang M; Hu W; Hua Y; He X; Peng B
Tumour Biol; 2016 Mar; 37(3):3433-40. PubMed ID: 26449826
[TBL] [Abstract][Full Text] [Related]
14. Prognostic relevance of pretherapeutic gamma-glutamyltransferase in patients with primary metastatic breast cancer.
Staudigl C; Concin N; Grimm C; Pfeiler G; Nehoda R; Singer CF; Polterauer S
PLoS One; 2015; 10(4):e0125317. PubMed ID: 25915044
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of efficacy between sorafenib and sunitinib as first-line therapy for metastatic renal cell carcinoma and analyze prognostic factors for survival].
Cai W; Yuan YC; Li MY; Kong W; Dong BJ; Chen YH; Zhang J; Xue W; Huang YR; Zhou LX; Huang JW
Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):384-389. PubMed ID: 29860767
[No Abstract] [Full Text] [Related]
16. γ-Glutamyltranspeptidase is a prognostic marker of survival and recurrence in radiofrequency-ablation treatment of hepatocellular carcinoma.
Ma H; Zhang L; Tang B; Wang Y; Chen R; Zhang B; Chen Y; Ge N; Wang Y; Gan Y; Ye S; Ren Z
Ann Surg Oncol; 2014 Sep; 21(9):3084-9. PubMed ID: 24748164
[TBL] [Abstract][Full Text] [Related]
17. Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Heng DY; Wells JC; Rini BI; Beuselinck B; Lee JL; Knox JJ; Bjarnason GA; Pal SK; Kollmannsberger CK; Yuasa T; Srinivas S; Donskov F; Bamias A; Wood LA; Ernst DS; Agarwal N; Vaishampayan UN; Rha SY; Kim JJ; Choueiri TK
Eur Urol; 2014 Oct; 66(4):704-10. PubMed ID: 24931622
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of gamma-glutamyl transferase in patients with metastatic non-small cell lung cancer.
Bozkaya Y; Yazıcı O
Expert Rev Mol Diagn; 2019 Mar; 19(3):267-272. PubMed ID: 30722710
[TBL] [Abstract][Full Text] [Related]
19. Association of post-treatment hypoalbuminemia and survival in Chinese patients with metastatic renal cell carcinoma.
Cai W; Zhang J; Chen Y; Kong W; Huang Y; Huang J; Zhou L
Chin J Cancer; 2017 May; 36(1):47. PubMed ID: 28521783
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of baseline serum C-reactive protein in patients with metastatic renal cell carcinoma (RCC) treated with sunitinib.
Beuselinck B; Vano YA; Oudard S; Wolter P; De Smet R; Depoorter L; Teghom C; Karadimou A; Zucman-Rossi J; Debruyne PR; Van Poppel H; Joniau S; Lerut E; Strijbos M; Dumez H; Paridaens R; Van Calster B; Schöffski P
BJU Int; 2014 Jul; 114(1):81-9. PubMed ID: 24215209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
